Format

Send to

Choose Destination
PLoS One. 2009;4(4):e5321. doi: 10.1371/journal.pone.0005321. Epub 2009 Apr 24.

Screening for C3 deficiency in newborns using microarrays.

Author information

1
Division of Clinical Immunology, Karolinska Institutet, KUS Huddinge, Stockholm, Sweden.

Abstract

BACKGROUND:

Dried blood spot samples (DBSS) from newborns are widely used in neonatal screening for selected metabolic diseases and diagnostic possibilities for additional disorders are continuously being evaluated. Primary immunodeficiency disorders comprise a group of more than one hundred diseases, several of which are fatal early in life. Yet, a majority of the patients are not diagnosed due to lack of high-throughput screening methods.

METHODOLOGY/PRINCIPAL FINDINGS:

We have previously developed a system using reverse phase protein microarrays for analysis of IgA levels in serum samples. In this study, we extended the applicability of the method to include determination of complement component C3 levels in eluates from DBSS collected at birth. Normal levels of C3 were readily detected in 269 DBSS from healthy newborns, while no C3 was detected in sera and DBSS from C3 deficient patients.

CONCLUSIONS/SIGNIFICANCE:

The findings suggest that patients with deficiencies of specific serum proteins can be identified by analysis of DBSS using reverse phase protein microarrays.

PMID:
19390687
PMCID:
PMC2669175
DOI:
10.1371/journal.pone.0005321
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center